...
机译:MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review
State Key Lab Mol Oncol,Chinese Acad Med Sci & Peking Union Med Coll;
TYROSINE KINASE INHIBITOR; RENAL-CELL CARCINOMA; PHASE-I; C-MET; LUNG-CANCER; PLUS ERLOTINIB; OPEN-LABEL; ACQUIRED-RESISTANCE; 2ND-LINE TREATMENT; ADVANCED NSCLC;